{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:06:13Z","timestamp":1772046373739,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ymgme.2009.10.002","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T19:33:28Z","timestamp":1255548808000},"page":"132-141","source":"Crossref","is-referenced-by-count":32,"title":["Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen"],"prefix":"10.1016","volume":"99","author":[{"given":"Dyane","family":"Auclair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Finnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joleen","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Kakkis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alphonsus","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2009.10.002_bib1","series-title":"The Metabolic Basis of Inherited Disease","first-page":"1565","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"1989"},{"key":"10.1016\/j.ymgme.2009.10.002_bib2","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198412203112504","article-title":"Bone marrow transplantation in the Maroteaux\u2013Lamy syndrome (mucopolysaccharidosis yype VI) biochemical and clinical status 24months after transplantation","volume":"311","author":"Krivit","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2009.10.002_bib3","first-page":"359","article-title":"Stem cell bone marrow transplantation in patients with metabolic storage diseases","volume":"49","author":"Krivit","year":"2002","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2009.10.002_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1023\/A:1005447232027","article-title":"Bone marrow transplantation for Maroteaux\u2013Lamy syndrome (MPS-VI): long term follow up","volume":"22","author":"Herskhovitz","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2009.10.002_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"MPS VI Study Group Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.10.002_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulphatase (recombinant human arylsulfatase B or RHASB) and follow-on open-label extension study","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2009.10.002_bib7","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","article-title":"MPS-VI Study Group. Direct comparison of measures of endurance mobilit yand joint function during enzyme replacement therapy of mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulphatase.","volume":"115","author":"Hartmatz","year":"2005","journal-title":"Pediatrics"},{"issue":"Suppl. 447","key":"10.1016\/j.ymgme.2009.10.002_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/08035320510028139","article-title":"Mucopolysaccharidosis VI Study Group. Pharmacokinetics profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome): a phase I\/II study","volume":"94","author":"Harmatz","year":"2005","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2009.10.002_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J. Pediatr."},{"issue":"Suppl.","key":"10.1016\/j.ymgme.2009.10.002_bib10","first-page":"582","article-title":"A phase I\/II study of enzyme replacement therapy (ERT) for mucopolysaccharidosis VI (MPS-VI; Maroteaux\u2013Lamy syndrome): 48 week progress report","volume":"71","author":"Harmatz","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2009.10.002_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI119208","article-title":"Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI","volume":"99","author":"Crawley","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.10.002_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1096-7192(03)00007-6","article-title":"Replacement therapy in mucopolysaccharidosis type VI: advantages of early onset of therapy","volume":"78","author":"Auclair","year":"2003","journal-title":"Mol. Gen. Metab."},{"key":"10.1016\/j.ymgme.2009.10.002_bib13","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI118617","article-title":"Replacement therapy in a feline model of Maroteaux\u2013Lamy syndrome","volume":"97","author":"Crawley","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.10.002_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S8756-3282(97)00175-0","article-title":"Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI","volume":"21","author":"Byers","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2009.10.002_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clineuro.2004.05.003","article-title":"Multilevel myelopathy in Maroteaux\u2013Lamy syndrome and review of literature","volume":"107","author":"Mut","year":"2005","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ymgme.2009.10.002_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000050383","article-title":"Neurosurgical interventions in children with Maroteaux\u2013Lamy syndrome. Case report and review of the literature","volume":"35","author":"Vougioukas","year":"2001","journal-title":"Pediatr. Neurosurg."},{"key":"10.1016\/j.ymgme.2009.10.002_bib17","first-page":"852","article-title":"Craniovetebral abnormalities in type VI mucopolysaccharidosis (Maroteaux\u2013Lamy syndrome)","volume":"48","author":"Thorne","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2009.10.002_bib18","first-page":"317","article-title":"Mucopolysaccharidosis 6-A (Maroteaux\u2013Lamy syndrome): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient","volume":"42","author":"Keller","year":"1987","journal-title":"Helv. Paediatr. Acta"},{"key":"10.1016\/j.ymgme.2009.10.002_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1227\/00006123-198709000-00027","article-title":"Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux\u2013Lamy syndrome: report of a case","volume":"21","author":"Tamaki","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2009.10.002_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1227\/00006123-198401000-00020","article-title":"Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux\u2013Lamy syndrome)","volume":"14","author":"Wald","year":"1984","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2009.10.002_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.410080321","article-title":"Compressive myelopathy in Maroteaux\u2013Lamy syndrome: clinical and pathological findings","volume":"8","author":"Young","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2009.10.002_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1148\/125.2.421","article-title":"Myelographic features of mucopolysaccharidoses: a new signs","volume":"125","author":"Sostrin","year":"1977","journal-title":"Radiology"},{"key":"10.1016\/j.ymgme.2009.10.002_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archneur.1975.00490440077013","article-title":"Myelopathy associated with Maroteaux\u2013Lamy syndrome","volume":"32","author":"Peterson","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2009.10.002_bib24","first-page":"223","article-title":"Mucopolysaccharidoses and spinal cord compression: case report and review of literature and implications of bone marrow transplantation","volume":"47","author":"Kachur","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymgme.2009.10.002_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0730-725X(87)90120-2","article-title":"Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses","volume":"5","author":"Kulkarni","year":"1987","journal-title":"Magn. Res. Imaging"},{"key":"10.1016\/j.ymgme.2009.10.002_bib26","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2174\/138161208784705504","article-title":"Lysosomal storage diseases and the blood\u2013brain barrier","volume":"14","author":"Begley","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgme.2009.10.002_bib27","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.10.002_bib28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1073\/pnas.0305480101","article-title":"Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis","volume":"101","author":"Kakkis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.10.002_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","article-title":"Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder","volume":"9","author":"Brooks","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymgme.2009.10.002_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/humu.20534","article-title":"Mutational analysis of 105 mucopolysaccharidosis type VI patients","volume":"28","author":"Karageorgos","year":"2007","journal-title":"Hum. mutat."},{"key":"10.1016\/j.ymgme.2009.10.002_bib31","doi-asserted-by":"crossref","first-page":"27259","DOI":"10.1074\/jbc.271.44.27259","article-title":"Feline mucopolysaccharidosis type VI: characterization of recombinant N-acetylgalactosamine 4-sulphatase and identification of a mutation causing the disease","volume":"271","author":"Yogalingam","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2009.10.002_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI935","article-title":"Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes","volume":"101","author":"Crawley","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.10.002_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ymgme.2007.04.009","article-title":"Long-term intra-articular administration of recombinant human N-acetylgalactosamine 4-sulfatase in feline mucopolysaccharidosis VI","volume":"91","author":"Auclair","year":"2007","journal-title":"Mol. Gen. Metab."},{"key":"10.1016\/j.ymgme.2009.10.002_bib34","first-page":"30","article-title":"Cerebrospinal fluid centesis at the cerebellomedullary cistern of kittens","volume":"41","author":"Hudson","year":"2002","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"10.1016\/j.ymgme.2009.10.002_bib35","first-page":"358","article-title":"Cerebrospinal fluid collection in rats: modification of a previous technique","volume":"44","author":"Hudson","year":"1994","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.ymgme.2009.10.002_bib36","series-title":"Veterinary Neuroanatomy and Clinical Neurology","author":"De LaHunta","year":"1983"},{"key":"10.1016\/j.ymgme.2009.10.002_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1208\/s12248-008-9043-6","article-title":"Development, validation, and clinical implementation of an assay to measure total antibody response to naglazyme (galsulfase)","volume":"10","author":"White","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.ymgme.2009.10.002_bib38","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/clinchem\/45.3.432","article-title":"Evaluation of the new ATSYM cyclosporine assay: comparison with TDx monoclonal whole blood and Emit cyclosporine assays","volume":"45","author":"Wallemacq","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2009.10.002_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1096-7192(03)00018-0","article-title":"Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry","volume":"78","author":"Ramsay","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.10.002_bib40","doi-asserted-by":"crossref","first-page":"36335","DOI":"10.1074\/jbc.274.51.36335","article-title":"Advantages of using same species enzyme replacement therapy in a feline model of mucopolysaccharidosis type VI","volume":"274","author":"Bielicki","year":"1999","journal-title":"J Biol. Chem."},{"key":"10.1016\/j.ymgme.2009.10.002_bib41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/mgme.1999.2859","article-title":"Immune response to enzyme replacement therapy: 4-sulfatase epitope of plasma antibodies from MPS-VI cats","volume":"67","author":"Turner","year":"1999","journal-title":"Mol. Gen. Met."},{"key":"10.1016\/j.ymgme.2009.10.002_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/bmmb.1994.1058","article-title":"Immunochemical characteristics of feline and human N-acetylgalactosamine 4-sulfatase","volume":"53","author":"Brooks","year":"1994","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.ymgme.2009.10.002_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.10.002_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.10.002_bib45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1203\/01.PDR.0000113789.30640.5C","article-title":"Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry","volume":"55","author":"Crawley","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2009.10.002_bib46","first-page":"769","article-title":"Mass spectrometry in the study of lysosomal storage disorders","volume":"49","author":"Meikle","year":"2003","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.ymgme.2009.10.002_bib47","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1097\/BRS.0b013e318145a360","article-title":"Complications of interlaminar cervical epidural steroid injections: a review of the literature","volume":"32","author":"Abbasi","year":"2007","journal-title":"Spine"},{"key":"10.1016\/j.ymgme.2009.10.002_bib48","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00007632-199810010-00020","article-title":"Cervical epidural steroid injection with intrinsic spinal cord damage. Two case reports","volume":"23","author":"Hodges","year":"1998","journal-title":"Spine"},{"key":"10.1016\/j.ymgme.2009.10.002_bib49","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","article-title":"Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression","volume":"146A","author":"Munoz-Rojas","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2009.10.002_bib50","unstructured":"D.D.G. Horovitz, M.V.R. Munoz, J.C. Llerena Jr., M.A.F.D. Lima, T.S.P.C. Magalhaes, A.T. Costa, L.B. Jardim, R. Cosa, T. Viera, F. Guarany, S. Fagondes, L. Vedolin, L. Azvedo, A.A.B. Pena e Costa, R.R. Barra, R.C. Domingues, E. Kakkis, D.F. Giovanetti, P.H. Mendes, L.M.C. Monteiro, R. Giugliani, Report of a MPS-VI child treated for spinal cord compression with intrathecal therapy, in: Proceedings of the 10thInternational Symposium on MPS and Related diseases, vol. 62, No. P48, 2008, Vancouver, BC, Canada."},{"key":"10.1016\/j.ymgme.2009.10.002_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1208\/s12248-008-9048-1","article-title":"Comparison of neutralizing antibody assays for receptor binding and enzyme activity of the enzyme replacement therapeutic naglazyme (galsulfase)","volume":"10","author":"White","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.ymgme.2009.10.002_bib52","unstructured":"K.M. Hemsley, E.J. Norman, A.C. Crawley, D. Auclair, B. King, M. Fuller, D.L. Lang, C.J. Dean, R.D. Jolly, J.J. Hopwood, Effect of cisternal sulfamidase delivery in, doi:10.1016\/j.ymgme.2009.07.013. MPS IIIA Huntaway dogs \u2013 a proof of principle study. Mol. Gen. Met., in press (MGM-09-184R1)."},{"key":"10.1016\/j.ymgme.2009.10.002_bib53","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1460-9568.2009.06666.x","article-title":"Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease","volume":"29","author":"Hemsley","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymgme.2009.10.002_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1601-183X.2008.00413.x","article-title":"Effect of high dose, repeated intra-CSF injection of sulphamidase on neuropathology in MPS IIIA mice","volume":"2","author":"Hemsley","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ymgme.2009.10.002_bib55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2006.10.005","article-title":"Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice","volume":"90","author":"Hemsley","year":"2007","journal-title":"Mol. Genet. Met."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209002820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209002820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T01:26:49Z","timestamp":1590197209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719209002820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1096719209002820"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2009.10.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}